CHMP extensions for Roche's Tarceva, Novartis' Afinitor and Wyeth's Enbrel
22 July 2011
John Hodgson
Please Login to read the full article.
22 July 2011
John Hodgson
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE drug wars: Tarceva vs Iressa, Revlimid vs IFN alpha, Botox vs SoC, and others
- Scotland says yes to BI/Lilly's Tradjenta and Lilly's Bydureon
- NICE no for Tyverb and Herceptin in breast cancer, Roche considers appeal
- Roche convinces NICE to add 'incremental' Tarceva as NSCLC treatment option
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
